Epium | London

Intel Plans Chip Production for Artificial Intelligence Servers

Intel to revamp its AI strategy, focusing on chip production for servers, amidst competition from Nvidia and AMD.

Intel is set to reinitiate its plan to manufacture chips tailored specifically for Artificial Intelligence servers. This move aims to regain market share against leading players like Nvidia and AMD who have made significant investments in start-ups innovating in chip technology.

The company’s strategy also includes potential joint ventures, such as discussions with TSMC about chipmaking collaborations. These partnerships could enhance Intel´s manufacturing capabilities, allowing it to strengthen its position in the AI server market.

Furthermore, Intel´s new CEO, Tan Lip-Bu, has announced plans to overhaul its AI operations, focusing on key areas beyond servers like software and robotics. His leadership is crucial as Intel seeks to replace lost engineering talent and align its manufacturing processes with customer demands.

Source

65

Impact Score

Latest News

Compression and voice models reshape Artificial Intelligence efficiency

March 31, 2026

Recent releases focused on infrastructure rather than headline model breakthroughs, with gains in compression and voice systems pointing to lower inference costs and broader deployment. Google and Mistral highlighted two distinct paths for real-time audio, while TurboQuant targeted one of the most expensive bottlenecks in long-context inference.

Judge blocks Pentagon move against Anthropic

March 31, 2026

A federal judge temporarily blocked the Pentagon from labeling Anthropic a supply chain risk after finding major gaps between public threats, legal authority, and the government’s courtroom arguments. The dispute has become a test of how far the government can go in punishing an Artificial Intelligence company over political and contractual conflict.

Anumana wins FDA clearance for pulmonary hypertension ECG Artificial Intelligence tool

March 30, 2026

Anumana has received FDA 510(k) clearance for an Artificial Intelligence-enabled pulmonary hypertension algorithm designed for use with standard 12-lead electrocardiograms. The company says the software can help clinicians spot early signs of disease within existing workflows and without moving patient data outside the health system environment.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.